Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.44 |
| ▸ | TRPA1 | O75762 | 3/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | NPC1 | O15118 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | MAOA | P21397 | 1/20 | 0.36 |
| ▸ | NOS3 | P29474 | 1/20 | 0.36 |
| ▸ | NOS1 | P29475 | 1/20 | 0.36 |
| ▸ | NOS2 | P35228 | 1/20 | 0.36 |
| ▸ | SRD5A2 | P31213 | 1/20 | 0.35 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | ACHE | P22303 | 2/20 | 0.34 |
| ▸ | BCHE | P06276 | 1/20 | 0.34 |
| ▸ | HRH1 | P35367 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL191346 | 0.82 | IDO1 (0.40) | HRH4ALDH1A1LMNAKDM4EMAPT | |
| SCHEMBL29349590 | 0.82 | IDO1 (0.40) | HRH4ALDH1A1LMNAKDM4EMAPT | |
| SCHEMBL21541520 | 0.71 | IDO1 (0.36) | ALDH1A1LMNAKDM4EMAPTRAB9A | |
| SCHEMBL13961627 | 0.70 | HRH4 (0.46) | HRH4TRPA1ALDH1A1LMNAKDM4E | |
| SCHEMBL8207110 | 0.69 | HRH4 (0.50) | HRH4TRPA1ALDH1A1LMNAKDM4E | |
| SCHEMBL85967 | 0.69 | HRH4 (0.54) | HRH4TRPA1ALDH1A1LMNAKDM4E | |
| SCHEMBL1772613 | 0.69 | HRH4 (0.50) | HRH4TRPA1ALDH1A1LMNAKDM4E | |
| SCHEMBL2720506 | 0.67 | ALDH1A1 (0.70) | ALDH1A1LMNAKDM4ENPC1MAPT | |
| SCHEMBL11780213 | 0.67 | NOS3 (0.43) | HRH4TRPA1ALDH1A1LMNANPC1 | |
| SCHEMBL23298998 | 0.67 | RAB9A (0.45) | HRH4TRPA1ALDH1A1LMNAKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12157837-B2 | Adhesive composition, method for producing surface-treated metal member, and method for producing metal-resin composite body | MEC COMPANY LTD. (JP) | 2024-12-03 | — | — | US | disclosed |
| EP-4039774-B1 | ORGANIC LIGHT-EMITTING MATERIAL AND ORGANIC LIGHT-EMITTING ELEMENT | NIPPON STEEL CHEMICAL & MAT CO LTD (JP) | 2023-09-20 | — | — | EP | disclosed |
| EP-4039774-A1 | ORGANIC LIGHT-EMITTING MATERIAL AND ORGANIC LIGHT-EMITTING ELEMENT | NIPPON STEEL Chemical & Material Co., Ltd. (JP) | 2022-08-10 | — | — | EP | disclosed |
| US-20220190257-A1 | FUNCTIONAL FILM, METHOD FOR FORMING SAME, AND ORGANIC ELECTROLUMINESCENT ELEMENT | Konica Minolta, Inc. (JP) | 2022-06-16 | — | — | US | disclosed |
| US-20220073793-A1 | ADHESIVE COMPOSITION, METHOD FOR PRODUCING SURFACE-TREATED METAL MEMBER, AND METHOD FOR PRODUCING METAL-RESIN COMPOSITE BODY | MEC COMPANY LTD. (JP) | 2022-03-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220190257-A1 | FUNCTIONAL FILM, METHOD FOR FORMING SAME, AND ORGANIC ELECTROLUMINESCENT ELEMENT | KCNQ2, KCNQ1, KCNQ4 | HRH4 1781/4885TRPA1 88/4885ALDH1A1 3664/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.